2.1505
-0.0695 (-3.13%)
-0.0695 (-3.13%)
Upgrade to Real-Time
Regular Market
| Volume | 101,282 |
|
|||||
| News | (1) | ||||||
| Day High | 2.23 | Low High |
|||||
| Day Low | 2.14 | ||||||
Best deals to access real time data! |
|
Ultimate Trader (Monthly)
Monthly Subscription
for only
|
|
Small Cap Basic
Monthly Subscription
for only
|
|
Big Cap Pro
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Onconova Therapeutics Inc | ONTX | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
 |
|
|---|---|---|---|---|
| -0.0695 | -3.13% | 2.1505 | 12:48:44 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 2.22 | 2.14 | 2.23 | 2.22 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 706 | 101,282 | $ 2.18 | $ 220,934 | - | 2.105 - 19.30 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 12:48:44 | 11 | $ 2.15 | USD |
Period:
Draw Mode:
Onconova Therapeutics Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 44.93M | 20.89M | 20.82M | $ 231.00k | $ - | -2.07 | -1.80 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | - | 1,000.00 | 3.70% |
Onconova Therapeutics News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical ONTX Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 2.35 | 2.45 | 2.105 | 2.26 | 251,108 | -0.1995 | -8.49% |
| 1 Month | 2.75 | 2.93 | 2.105 | 2.54 | 317,736 | -0.5995 | -21.8% |
| 3 Months | 3.46 | 3.74 | 2.105 | 2.99 | 347,340 | -1.31 | -37.85% |
| 6 Months | 4.90 | 6.7699 | 2.105 | 5.23 | 1,136,796 | -2.75 | -56.11% |
| 1 Year | 8.05 | 19.30 | 2.105 | 11.25 | 13,918,127 | -5.90 | -73.29% |
| 3 Years | 20.20 | 52.50 | 1.027 | 7.47 | 11,874,251 | -18.05 | -89.35% |
| 5 Years | 414.00 | 582.00 | 1.027 | 10.81 | 7,380,547 | -411.85 | -99.48% |
Onconova Therapeutics Description
| Onconova Therapeutics Inc is a biopharmaceutical company focused on discovering and developing novel products to treat cancer. The company has proprietary targeted anti-cancer agents designed to disrupt specific cellular pathways that are important for cancer cell proliferation. Onconova's novel, proprietary multi-kinase inhibitor ON 123300 is currently in a dose-escalation and expansion Phase 1 trial in China, and an IND has been filed in the U.S. Its product candidate oral rigosertib is currently in a dose-escalation and expansion Phase 1 investigator-initiated study targeting patients with KRAS+ lung adenocarcinoma in combination with nivolumab. |